Optimal doses of paclitaxel and carboplatin combination chemotherapy for ovarian cancer: a phase I modified continual reassessment method study.
Kuzuya K, Ishikawa H, Nakanishi T, Kikkawa F, Nawa A, Fujimura H, Iwase A, Arii Y, Kawai M, Hattori S, Sakakibara K, Sasayama E, Furuhashi Y, Suzuki T, Mizutani S; Tokai Gynecologic Oncology Group.
Kuzuya K, et al. Among authors: iwase a.
Int J Clin Oncol. 2001 Dec;6(6):271-8. doi: 10.1007/s10147-001-8027-7.
Int J Clin Oncol. 2001.
PMID: 11828945
Clinical Trial.